Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Oral Cavity & Pharynx (All Stages^), 2016-2020

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Rate
State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate ascending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Recent Trend
Recent 5-Year Trend in Incidence Rates
(95% Confidence Interval)
 sort by trend descending
US (SEER+NPCR) 1 11.9 (11.9, 12.0) N/A 46,507 stable stable trend 0.0 (-0.4, 0.6)
West Virginia 6 14.3 (13.6, 15.0) 1 (1, 8) 358 rising rising trend 2.0 (1.3, 2.7)
Iowa 7 14.2 (13.6, 14.7) 2 (1, 7) 561 rising rising trend 2.6 (1.8, 4.7)
Maine 6 13.9 (13.1, 14.7) 3 (1, 14) 276 stable stable trend 1.6 (-0.4, 4.5)
Florida 6 13.9 (13.7, 14.1) 4 (1, 7) 4,173 stable stable trend 0.2 (-0.1, 0.6)
Arkansas 6 13.8 (13.3, 14.3) 5 (1, 12) 518 rising rising trend 1.7 (1.3, 2.1)
Kentucky 7 13.6 (13.1, 14.0) 6 (1, 12) 761 stable stable trend -0.8 (-4.2, 1.1)
North Dakota 6 13.1 (12.0, 14.3) 7 (1, 37) 114 stable stable trend 0.9 (-0.4, 2.3)
Mississippi 6 13.1 (12.6, 13.6) 8 (3, 26) 478 stable stable trend 0.2 (-0.5, 0.9)
Louisiana 7 13.0 (12.6, 13.5) 9 (5, 25) 732 rising rising trend 0.7 (0.4, 1.1)
Oklahoma 6 13.0 (12.5, 13.5) 10 (5, 27) 611 stable stable trend 0.7 (-0.2, 1.6)
Hawaii 7 13.0 (12.2, 13.8) 11 (2, 33) 234 rising rising trend 0.7 (0.3, 1.2)
Tennessee 6 12.9 (12.6, 13.3) 12 (6, 24) 1,102 falling falling trend -1.0 (-1.9, -0.1)
Missouri 6 12.9 (12.5, 13.2) 13 (6, 26) 1,003 rising rising trend 1.1 (0.7, 1.5)
Nebraska 6 12.8 (12.1, 13.5) 14 (4, 34) 293 rising rising trend 1.2 (0.5, 2.0)
Minnesota 6 12.6 (12.2, 13.0) 15 (7, 31) 870 rising rising trend 1.1 (0.6, 1.7)
Wisconsin 6 12.6 (12.3, 13.0) 16 (8, 31) 952 rising rising trend 1.2 (0.7, 1.8)
Ohio 6 12.6 (12.3, 12.8) 17 (10, 29) 1,886 rising rising trend 1.9 (1.7, 2.3)
North Carolina 6 12.6 (12.3, 12.8) 18 (10, 29) 1,626 rising rising trend 0.8 (0.3, 1.4)
Alabama 6 12.6 (12.2, 13.0) 19 (8, 32) 780 stable stable trend -0.4 (-2.3, 0.2)
Vermont 6 12.5 (11.5, 13.7) 20 (2, 43) 109 rising rising trend 1.3 (0.3, 2.6)
Georgia 7 12.5 (12.3, 12.8) 21 (9, 30) 1,512 stable stable trend 1.1 (0.0, 3.5)
South Carolina 6 12.5 (12.1, 12.9) 22 (8, 32) 836 stable stable trend 0.2 (-0.3, 0.8)
Washington 5 12.5 (12.2, 12.8) 23 (10, 31) 1,122 rising rising trend 1.1 (0.7, 1.5)
Pennsylvania 6 12.4 (12.2, 12.7) 24 (12, 31) 2,133 rising rising trend 1.5 (1.3, 1.7)
South Dakota 6 12.3 (11.3, 13.3) 25 (4, 43) 131 stable stable trend 1.2 (-0.3, 2.8)
New Hampshire 6 12.2 (11.5, 13.0) 26 (7, 42) 233 rising rising trend 0.7 (0.1, 1.4)
Idaho 7 12.2 (11.5, 12.9) 27 (8, 41) 259 stable stable trend 0.5 (-0.5, 1.5)
Oregon 6 12.2 (11.7, 12.6) 28 (13, 36) 656 rising rising trend 1.2 (0.7, 1.9)
Illinois 7 12.2 (11.9, 12.4) 29 (19, 34) 1,892 rising rising trend 0.9 (0.6, 1.1)
Alaska 6 12.1 (11.0, 13.3) 30 (4, 44) 96 stable stable trend 0.8 (-0.3, 2.0)
Connecticut 7 12.1 (11.6, 12.6) 31 (13, 38) 573 rising rising trend 1.3 (1.0, 1.7)
Montana 6 12.1 (11.2, 13.0) 32 (7, 43) 170 stable stable trend 0.5 (-0.4, 1.5)
Delaware 6 11.9 (11.0, 12.8) 33 (8, 44) 156 rising rising trend 1.0 (0.2, 1.9)
Michigan 6 11.8 (11.6, 12.1) 34 (25, 38) 1,534 stable stable trend 0.5 (0.0, 1.1)
Kansas 6 11.7 (11.2, 12.2) 35 (21, 43) 408 stable stable trend -1.7 (-4.0, 0.7)
Massachusetts 7 11.6 (11.3, 12.0) 36 (28, 41) 1,027 rising rising trend 0.5 (0.2, 0.9)
Virginia 6 11.5 (11.2, 11.8) 37 (30, 43) 1,186 rising rising trend 1.0 (0.5, 1.5)
New Jersey 7 11.4 (11.2, 11.7) 38 (31, 43) 1,298 rising rising trend 0.9 (0.6, 1.3)
New York 7 11.3 (11.1, 11.5) 39 (34, 43) 2,773 rising rising trend 1.0 (0.8, 1.2)
Texas 7 11.2 (11.1, 11.4) 40 (35, 44) 3,377 stable stable trend 0.7 (-0.4, 2.4)
Maryland 6 11.1 (10.7, 11.4) 41 (35, 45) 828 rising rising trend 0.9 (0.3, 1.5)
Rhode Island 6 11.0 (10.2, 11.8) 42 (26, 46) 156 rising rising trend 1.1 (0.2, 2.0)
Wyoming 6 10.8 (9.7, 12.0) 43 (21, 48) 78 stable stable trend 0.1 (-1.6, 1.9)
Colorado 6 10.8 (10.4, 11.1) 44 (38, 45) 703 rising rising trend 1.1 (0.7, 1.6)
District of Columbia 6 10.2 (9.1, 11.3) 45 (33, 49) 71 falling falling trend -2.1 (-3.7, -0.6)
California 7 10.1 (10.0, 10.2) 46 (44, 47) 4,538 falling falling trend -0.3 (-0.7, -0.2)
Utah 7 9.5 (9.0, 10.0) 47 (45, 49) 272 stable stable trend -3.1 (-6.6, 2.0)
New Mexico 7 9.1 (8.6, 9.7) 48 (46, 49) 242 falling falling trend -0.6 (-1.0, -0.2)
Arizona 6 9.0 (8.7, 9.3) 49 (46, 49) 816 stable stable trend 0.0 (-0.5, 0.6)
Puerto Rico 6 8.9 (8.4, 9.3) N/A 369 stable stable trend -3.0 (-8.4, 2.7)
Indiana 6
data not available
N/A
data not available
data not available
data not available
Nevada 6
data not available
N/A
data not available
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 09/30/2023 3:36 pm.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
‡ Incidence data come from different sources. Due to different years of data availability, most of the trends are AAPCs based on APCs but some are APCs calculated in SEER*Stat. Please refer to the source for each area for additional information.

Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage.
Data not available for this combination of data selections.

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.
5 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2022 submission).
7 Source: SEER November 2022 submission.
8 Source: Incidence data provided by the SEER Program. AAPCs are calculated by the Joinpoint Regression Program and are based on APCs. Data are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84,85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Population counts for denominators are based on Census populations as modifed by NCI. The US Population Data File is used with SEER November 2022 data.

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top